News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
EU Advisor Recommends Regulatory Exemption for Gene Editing
Catherine Offord | Jan 18, 2018
Crops produced using mutagenic technologies such as CRISPR should generally be exempt from regulatory laws governing GMOs, according to the published opinion.
Gilead’s CAR T-Cell Therapy Administered to Just Five Patients in Two Months
Catherine Offord | Dec 17, 2017
More than 200 people are on waiting lists for the $373,000 treatment as hospitals try to work around problems with insurers.
USDA Buys Animals from Farm It Reported for Animal Welfare Abuses
Katarina Zimmer | Nov 14, 2017
The federal agency has so far not taken any enforcement action against Ruby Fur Farm.
Mass Resignation from
’s Editorial Board
Catherine Offord | Nov 6, 2017
Nineteen researchers have stepped down after the journal decided not to retract a paper that they say plagiarized the work of a Johns Hopkins biomedical scientist.
Report: Security Lapses in Handling of Deadly Pathogens
Katarina Zimmer | Oct 31, 2017
A government report finds that laboratories in the U.S. that work with select agents such as Ebola and anthrax aren’t as secure as they should be.
WHO Cherry-Picked Data on Pesticide, Investigation Finds
Ashley P. Taylor | Oct 22, 2017
A group evaluating glyphosate’s cancer risk omitted evidence that the chemical is not carcinogenic.
Great Lakes Gray Wolf to Retain Endangered Status
Catherine Offord | Aug 2, 2017
A US Court of Appeals ruled that the Interior Department acted prematurely in removing the animals from the endangered species list.
New FDA Pathway to Accelerate Development of Cell Therapies
Jef Akst | May 22, 2017
Four products have already qualified for the regenerative medicine advanced therapy (RMAT) designation that provides extra interactions with the agency, and sooner.
Diana Kwon | Apr 1, 2017
Meet some of the people featured in the April 2017 issue of
Book Excerpt from
The Politics of Cancer
Wendy N. Whitman Cobb | Mar 31, 2017
In Chapter 2, “Identifying the Culprits,” author Wendy Whitman Cobb describes how small-government, anti-regulation conservatism can hinder the fight against cancer.